Double (V27A/S31N) mutant 2009 pandemic influenza A (H1N1) virus isolated from adamantane non-treated inmunocompetent child

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 1, 2010, Pages 114-115

  Antón, Andrés ^a   Marcos, María Ángeles ^a   Martínez, Miguel Julián ^a   Ramón, Susana ^a   Isanta, Ricard ^a   de Molina, Patricia ^a   de Anta, María Teresa Jiménez ^a   Pumarola, Tomàs ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Influenza; Mutant; Pandemic

Indexed keywords

ADAMANTANE;

ADOLESCENT; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA VIRUS A H1N1; NASOPHARYNX; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROAT CULTURE; VIRUS ISOLATION; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN;

ADAMANTANE; ADOLESCENT; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MUTATION, MISSENSE; SPAIN; VIRAL MATRIX PROTEINS;

EID: 77951498646     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.12.019     Document Type: Article

References (7)

1. Abed Y., Goyette N., Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob. Agents Chemother. 2005, 49:556-559.
2. Centers for Disease Control and Prevention, CDC Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb. Mortal Wkly. Rep. 2009, 58:433-435.
3. European Centre for Disease Prevention and Control, ECDC ECDC Influenza A(H1N1)v: common case definition From. http://ecdc.europa.eu/en/healthtopics/Pages/Influenza_A(H1N1)_Common_Case_Definition.aspx.
4. Hay A.J., Wolstenholme A.J., Skehel J.J., Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985, 4:3021-3024.
5. Krumbholz A., Schmidtke M., Bergmann S., Motzke S., Bauer K., Stech J., Dürrwald R., Wutzler P., Zell R. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J. Gen. Virol. 2009, 90(Pt 4):900-908.
6. Schnell J.R., Chou J.J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 2008, 451:591-595.
7. Shiraishi K., Mitamura K., Sakai-Tagawa Y., Goto H., Sugaya N., Kawaoka Y. High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis 2003, 188:57-61.